Followers | 29 |
Posts | 1427 |
Boards Moderated | 0 |
Alias Born | 11/15/2006 |
Monday, May 30, 2022 9:50:23 AM
Print item:Tenon Medical, Inc. Announces Upcoming Virtual Conference Participation View PDF item:Tenon Medical, Inc. Announces Upcoming Virtual Conference Participation
LOS GATOS, CA / ACCESSWIRE / May 25, 2022 / Tenon Medical, Inc. ("Tenon" or the "Company"), a medical device company that has developed a proprietary, U.S. Food and Drug Administration ("FDA") cleared surgical implant system for sacroiliac joint ("SI Joint") fixation/fusion surgery, today announced the Company will participate in The Benchmark Company Healthcare House Call Virtual 1x1 Investor Conference on Thursday, June 2, 2022.
Richard Ferrari, Founder and Executive Chairman, Steve Foster, CEO and President, and Steven Van Dick, CFO, will attend and will be available for virtual one-on-one and small group meetings.
For more information on the conference, please contact your conference representative. Meeting requests may also be emailed to tenon@mzgroup.us.
About Tenon Medical, Inc.
Tenon Medical, Inc., a medical device company formed in 2012, has developed a proprietary, FDA cleared surgical implant system, which is designed to optimize SI-Joint fixation / fusion surgery and corresponding outcomes. Tenon is preparing a national launch of this system to address the greatly underserved market opportunity that exists in this space.
Investor Contact
Shannon Devine
MZ North America
203-741-8811
tenon@mzgroup.us
Recent TNON News
- Healthcare Stock Bid Up Before Opening Bell • AllPennyStocks.com • 03/13/2024 02:05:00 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 02/28/2024 04:01:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 10:23:54 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 06:07:10 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/31/2024 09:27:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 10:30:57 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/10/2024 09:16:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 06:49:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 09:15:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 10:20:21 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/22/2023 11:10:26 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/08/2023 10:06:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 09:27:13 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/22/2023 07:55:23 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/11/2023 08:18:50 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 09/11/2023 07:05:10 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/08/2023 08:41:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 07:32:03 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 09:06:10 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM